Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study.
Tedesco-Silva H, Pascual J, Viklicky O, Basic-Jukic N, Cassuto E, Kim DY, Cruzado JM, Sommerer C, Adel Bakr M, Garcia VD, Uyen HD, Russ G, Soo Kim M, Kuypers D, Buchler M, Citterio F, Hernandez Gutierrez MP, Bernhardt P, Chadban S; TRANSFORM Investigators.
Tedesco-Silva H, et al. Among authors: kim dy.
Transplantation. 2019 Sep;103(9):1953-1963. doi: 10.1097/TP.0000000000002626.
Transplantation. 2019.
PMID: 30801548
Clinical Trial.